Leading the Way in Life Science Technologies

GEN Exclusives

More »

February 15, Vol. 37, No. 4

  • Feature Articles

    • Markets Expand for Single-Use Bioreactors
    • Angelo DePalma
    • Single-use bioreactors are steadily encroaching on territory where previously only fixed-tank processes dared tread Such incursions, along with consolidations of existing strongholds, help explain why single-use bioreactors are gaining ground so quickly... more »
    • Good Assays for Bad Immunogenicity
    • Vicki Glaser
    • With some medical interventions, immunogenicity is the whole point—hence the “good” immunogenicity provoked by vaccines Immunogenicity is much to be avoided, however, when biotherapeutics are deployed Biotherapeutics such as recombinant proteins or monoclonal antibodies (mAbs) may instigate “bad” immunogenicity, potentially ... more »
    • Reading miRNAs for Clinical Meaning
    • Richard A. Stein
    • Soon after it was established that less than 2% of the human genome encodes for proteins, it was supposed that the vast majority of genetic material was mere junk Subsequently, after advances to genomics and transcriptomics technology, scientists realized that the remaining ... more »